CEO Accepts 2002 Catalyst Award in New York
NEW YORK, April 12 /PRNewswire/ -- Noting that his two adult daughters,
both successful professionals, are "walking on the ground that was prepared by
Catalyst," Bayer Corporation President and CEO Helge H. Wehmeier Thursday
evening accepted one of three 2002 Catalyst Awards honoring companies with
successful innovative approaches to attract, retain and prepare women and
minorities for leadership positions.
"As friends and supporters of Catalyst, we share with many other like-
minded advocates of diversity and fairness the common belief that fair
treatment and equal opportunity is simply the right thing to do," Wehmeier
said.
Bayer Corporation joined Fannie Mae and Marriott International Inc., as
Catalyst Award honorees at the organization's 40th Anniversary conference and
dinner Thursday in New York. Catalyst is a nonprofit research and advisory
organization working to advance women in business and the professions. Since
1987, Catalyst has annually honored companies for outstanding, proven
initiatives to advance women.
During Thursday's conference, two Bayer executives presented break-out
sessions detailing the company's award-winning initiative, Bayer Women:
Leaders for the Global Marketplace. They were Connie Dunn, Vice President,
Human Resources Services & Employee Relations at Bayer's U.S. Corporate
Headquarters in Pittsburgh; and Dr. Lora Rand, Vice President Manufacturing,
Plastics Division in Baytown, Texas. Also participating was Diana Kamyk,
Bayer Manager, Workforce Diversity and Work/Life Practices.
Bayer's successful program embraces diversity awareness training, multiple
mentoring programs, career development and international delegate programs,
employee networks and succession planning with executive accountability.
Bayer's Associate Development Program is designed to increase the ratio of
females and minorities in high potential candidate pools; in the Delegate
Career Development Program women and minority candidates are given overseas
assignments of two-to-three years duration.
"As part of a global company, we recognize the business case for workforce
diversity," Wehmeier said. "On behalf of the 22,000 employees of Bayer in the
United States it gives me great pleasure and immense pride to accept this
award."
Best known for its flagship product, Bayer Aspirin, Bayer Corporation
produces a broad range of health care, life sciences and chemical products
found not just in medicine cabinets, but in nearly every bedroom, living room,
kitchen, garage, hospital, farm and factory across America. Bayer products
help diagnose and treat diseases, purify water, preserve local landmarks,
protect crops, advance automobile safety and durability and improve people's
lives.
The $10 billion company, one of Fortune magazine's Most Admired Companies,
promotes science literacy and hands-on education through its Making Science
Make Sense educational initiative. Approximately five percent of Bayer's
22,000 employees volunteer in local schools, and more than 500 charitable
organizations receive funding from the Bayer Foundation.
Headquartered in Pittsburgh, Bayer Corporation is a member of the
worldwide Bayer Group, a $27 billion international health care and chemicals
group based in Leverkusen, Germany. The Bayer Group stock is a component of
the DAX and is listed on the New York Stock Exchange (ticker symbol: BAY).
Forward-Looking Statements
This news release contains forward-looking statements based on current
assumptions and forecasts made by Bayer Group management. Various known and
unknown risks, uncertainties and other factors could lead to material
differences between the actual future results, financial situation,
development or performance of the company and the estimates given here. These
factors include those discussed in our public reports filed with the Frankfurt
Stock Exchange and with the U.S. Securities and Exchange Commission (including
our Form 20-F). The company assumes no liability whatsoever to update these
forward-looking statements or to conform them to future events or
developments.
SOURCE Bayer Corporation